Experts Explain

Making decisions about your treatment, including whether or not to participate in a clinical trial, can be challenging. Many women find it helpful to speak with someone who has participated in a clinical trial as well as with a trusted physician, family members and friends.

There may also be support services offered at your local clinic or in your community. These services may include help with financial issues related to treatment, transportation issues, childcare, and emotional stress, to name just a few. Local and online peer support groups are often also available.

Hear From The I-SPY 2 Trial Experts

The following videos feature I-SPY 2 physicians and researchers discussing various topics related to the trial. The topics discussed in each video are listed below.

Play Video
Play Video

Angela DeMichele, MD, MSCE

Alan and Jill Miller Professor in Breast Cancer Excellence
Perelman Center for Advanced Medicine
University of Pennsylvania
I-SPY 2 Principal Investigator

  • Important learning from I-SPY 2
  • Patient safety on I-SPY 2

Length: 2:00 min

Play Video

Judy Boughey, MD

Surgeon
Mayo Clinic, Rochester, Minnesota
I-SPY 2 Surgery Committee Chair

  • What makes I-SPY 2 different from other trials?
  • Which patients are candidates for I-SPY 2?
  • Which costs are covered by the trial?

Length: 2:17 min

Play Video

Laura van ‘t Veer, PhD

Professor of Laboratory Medicine
University of California, San Francisco
I-SPY 2 Biomarker Committee Chair

  • Breast cancer is more than one disease
  • Why are biopsies used in I-SPY 2?
  • What is a biomarker and how is it used?

Length: 1:57 min

Play Video

Douglas Yee, MD

Professor of Medicine and Pharmacology, University of Minnesota
Director, Masonic Cancer Center
I-SPY 2 Investigational Drug Selection Committee Chair

  • What is adaptive randomization and why is it used in the I-SPY 2 Trial?
  • How does the I-SPY 2 Trial speed up access to effective new treatments?
  • What is pathological complete response (PCR)?

Length: 2:18 min

If you enrolled in I-SPY 2 on or after June 23, 2022 or are interested in joining the trial, we encourage you to take the time to watch these next 2 introductory videos to get a good understanding of how the I-SPY 2 Trial works and what you can expect if you participate.

Introduction to the I-SPY 2 Trial

Angela DeMichele, MD, MSCE

Alan and Jill Miller Professor in Breast Cancer Excellence
Perelman Center for Advanced Medicine
University of Pennsylvania
I-SPY 2 Principal Investigator

  • :00 Introduction to the video
  • :52 What is the I-SPY 2 Trial
  • 2:14 Informed Consent process
  • 3:16 Screening for eligibility to participate
  • 4:40 What is a Functional Tumor Volume MRI?
  • 6:36 Response Predictive Subtypes and the I-SPY Biopsy
  • 7:37 Your treatment on I-SPY 2 Trial
  • 10:40 Shared Test Results and Shared Decision Making
  • 11:20 Treatment Strategy of I-SPY 2
  • 13:55 How the MRI is used in I-SPY 2
  • 17:03 Deciding whether to go to surgery early
  • 18:35 Summary of the video

 

Length: 18:35 min

Introduction to the I-SPY 2 Trial

Douglas Yee, MD

Professor of Medicine and Pharmacology, University of Minnesota
Director, Masonic Cancer Center
I-SPY 2 Investigational Drug Selection Committee Chair

Length: 2:15 min

Information About I-SPY 2 Trial Study Procedures

  • Mammogram-Guided Core Needle Biopsy 2:07
  • Mammogram-Guided Core Needle Biopsy #2 3:42
  • Mammogram-Guided Core Needle Biopsy #2 (Spanish) 3:42
  • Mammogram-Guided Core Needle Biopsy #2 (Mandarin) 3:42
  • Mammogram-Guided Core Needle Biopsy #2 (Russian) Ultrasound-Guided Core Needle Biopsy 3:23
  • Ultrasound-Guided Core Needle Biopsy (Spanish) 3:23
  • Ultrasound-Guided Core Needle Biopsy (Mandarin) 3:23
  • Ultrasound-Guided Core Needle Biopsy (Russian) 3:23

Understanding A Breast Pathology Report

Presented by
Ron Balassanian, MD
Professor of Pathology | University of California, San Francisco

This series of 5 short videos will guide you through understanding your breast pathology report.

Play Video

Breast Pathology Report Video 01:

Reading and Understanding Your Pathology Report

Length: 4:06 min
Play Video

Breast Pathology Report Video 02:

Tissue Sample Collection and Gross Description

Length: 7:46 min
Play Video

Breast Pathology Report Video 03:

Looking Through the Microscope

Length: 13:27 min
Play Video

Breast Pathology Report Video 04:

Exploring Special Tests and Markers

Length: 6:32 min
Play Video

Breast Pathology Report Video 05

Unpacking the Diagnosis and Summary

Length: 4:17 min
Play Video

Nola Hylton, PhD

Professor of Radiology, University of California, San Francisco
I-SPY 2 Imaging Committee Chair

  • What is an MRI and how is it used in I-SPY 2?
  • What to expect when getting an MRI (step by step explanation)
  • Who can’t get an MRI?

Length: 2:18 min

MammaPrint Test

  • MammaPrint Patient Brochure from Agendia, Inc. (Download .pdf)
  • MammaPrint Patient Brochure< from Agendia, Inc. (Spanish) (Download .pdf)

Other Resources

  • Downloadable National Cancer Institute (NCI) booklet helpful, “Taking Part in Cancer Treatment Research Studies”.
  • Download this list of questions to ask before joining a clinical trial
The pros and cons of neoadjuvant therapy
  • I-SPY Patient Fact Sheet Patient Fact Sheet
  • List of more than 20 investigational drugs that I-SPY has already tested. More than a dozen of these drugs are more beneficial for patients than standard therapy.
  • Cleveland Clinic’s Drug Information Site Chemocare.com to learn more about the standard and investigational drugs on the I-SPY 2 Trial.

Transportation, lodging and other treatment-related financial resources

Air transportation

Air Care Alliance aircarealliance.org, 888-260-9707
Air Charity Network www.aircharitynetwork.org, 877-621-7177
Angel Flight Central angelflightcentral.org, 866-569-9464 (Small planes)
Corporate Angel Network (CAN) corpangelnetwork.org, 914-328-1313
Lifeline Pilots lifelinepilots.org, 800-822-7972 (States in US mid to east)
Mercy Medical Angels www.mercymedical.org, 757-318-9174 (Flights or ground transportation)
Patient AirLift Services www.palservices.org, 888-818-1231 (Small planes)

Ground transportation

Air Care Alliance aircarealliance.org, 888-260-9707
Air Charity Network www.aircharitynetwork.org, 877-621-7177
Angel Flight Central angelflightcentral.org, 866-569-9464 (Small planes)
Corporate Angel Network (CAN) corpangelnetwork.org, 914-328-1313
Lifeline Pilots lifelinepilots.org, 800-822-7972 (States in US mid to east)
Mercy Medical Angels www.mercymedical.org, 757-318-9174 (Flights or ground transportation)
Patient AirLift Services www.palservices.org, 888-818-1231 (Small planes)

Lodging

Air Care Alliance aircarealliance.org, 888-260-9707
Air Charity Network www.aircharitynetwork.org, 877-621-7177
Angel Flight Central angelflightcentral.org, 866-569-9464 (Small planes)
Corporate Angel Network (CAN) corpangelnetwork.org, 914-328-1313
Lifeline Pilots lifelinepilots.org, 800-822-7972 (States in US mid to east)
Mercy Medical Angels www.mercymedical.org, 757-318-9174 (Flights or ground transportation)
Patient AirLift Services www.palservices.org, 888-818-1231 (Small planes)

Help with other expenses

Air Care Alliance aircarealliance.org, 888-260-9707
Air Charity Network www.aircharitynetwork.org, 877-621-7177
Angel Flight Central angelflightcentral.org, 866-569-9464 (Small planes)
Corporate Angel Network (CAN) corpangelnetwork.org, 914-328-1313
Lifeline Pilots lifelinepilots.org, 800-822-7972 (States in US mid to east)
Mercy Medical Angels www.mercymedical.org, 757-318-9174 (Flights or ground transportation)
Patient AirLift Services www.palservices.org, 888-818-1231 (Small planes)

Trial Locations

After reviewing the resources and hearing from experts, you can find answers to any more questions or express your interest in participating in the study by checking the I-SPY 2 Trial Locations page for the nearest site to you.

Hear from I-SPY 2 Trial Participants

You can also hear from some I-SPY 2 trial participants as they discuss how they decided to participate and how they feel about their experiences on the trial.
Contact Us
Investigators Portal
QLHC in the News
Working at QL
Contact Us